National Research Corporation (NASDAQ:NRC – Get Free Report) announced a quarterly dividend on Wednesday, April 15th. Stockholders of record on Friday, June 26th will be paid a dividend of 0.16 per share on Friday, July 10th. This represents a c) annualized dividend and a dividend yield of 3.2%. The ex-dividend date of this dividend is Friday, June 26th.
National Research has raised its dividend by an average of 0.2%annually over the last three years.
National Research Stock Up 2.8%
Shares of NRC opened at $20.04 on Wednesday. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 5.48. The company has a 50-day moving average price of $18.56 and a two-hundred day moving average price of $17.71. The stock has a market cap of $455.91 million, a price-to-earnings ratio of 51.38 and a beta of 0.37. National Research has a 12 month low of $11.01 and a 12 month high of $22.79.
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of NRC. Bank of America Corp DE raised its position in National Research by 3.0% in the 1st quarter. Bank of America Corp DE now owns 112,468 shares of the company’s stock valued at $1,910,000 after purchasing an additional 3,323 shares during the last quarter. Empowered Funds LLC bought a new stake in shares of National Research during the first quarter worth $226,000. Quantinno Capital Management LP grew its holdings in shares of National Research by 61.3% during the first quarter. Quantinno Capital Management LP now owns 62,329 shares of the company’s stock worth $1,058,000 after purchasing an additional 23,682 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of National Research by 4.0% in the first quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock valued at $4,257,000 after buying an additional 9,730 shares in the last quarter. Finally, Fifth Third Bancorp acquired a new stake in shares of National Research in the first quarter valued at $1,531,000. Institutional investors own 47.26% of the company’s stock.
About National Research
National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.
Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.
Further Reading
- Five stocks we like better than National Research
- The SpaceX Sell-Off May Be More Than a Market Overreaction
- Chevron’s Microsoft Deal Turns Natural Gas Into an AI Trade
- Why nVent Could Be a Long-Term AI Infrastructure Winner
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.
